Updates
MCI Clinical Trial: Vielight itPBM and Memory, Brain Energy, and Inflammation
Toronto, Ontario. A new randomized, sham-controlled pilot study published in the Journal of Alzheimer’s Disease (June 2026) reports that home-based intranasal-transcranial photobiomodulation (itPBM) with the Vielight Neuro produced measurable improvements across cognition, brain metabolism, and brain-network connectivity in adults with mild cognitive impairment (MCI). The independent study was conducted by researchers at St. Michael’s Hospital and the University […]